HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis.

Abstract
Osteoarthritis is a highly prevalent and debilitating joint disorder. There is no effective medical therapy for the condition because of limited understanding of its pathogenesis. We show that transforming growth factor β1 (TGF-β1) is activated in subchondral bone in response to altered mechanical loading in an anterior cruciate ligament transection (ACLT) mouse model of osteoarthritis. TGF-β1 concentrations are also high in subchondral bone from humans with osteoarthritis. High concentrations of TGF-β1 induced formation of nestin-positive mesenchymal stem cell (MSC) clusters, leading to formation of marrow osteoid islets accompanied by high levels of angiogenesis. We found that transgenic expression of active TGF-β1 in osteoblastic cells induced osteoarthritis, whereas inhibition of TGF-β activity in subchondral bone attenuated the degeneration of articular cartilage. In particular, knockout of the TGF-β type II receptor (TβRII) in nestin-positive MSCs led to less development of osteoarthritis relative to wild-type mice after ACLT. Thus, high concentrations of active TGF-β1 in subchondral bone seem to initiate the pathological changes of osteoarthritis, and inhibition of this process could be a potential therapeutic approach to treating this disease.
AuthorsGehua Zhen, Chunyi Wen, Xiaofeng Jia, Yu Li, Janet L Crane, Simon C Mears, Frederic B Askin, Frank J Frassica, Weizhong Chang, Jie Yao, John A Carrino, Andrew Cosgarea, Dmitri Artemov, Qianming Chen, Zhihe Zhao, Xuedong Zhou, Lee Riley, Paul Sponseller, Mei Wan, William Weijia Lu, Xu Cao
JournalNature medicine (Nat Med) Vol. 19 Issue 6 Pg. 704-12 (Jun 2013) ISSN: 1546-170X [Electronic] United States
PMID23685840 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Receptors, Transforming Growth Factor beta
  • Transforming Growth Factor beta
  • Protein Serine-Threonine Kinases
  • Receptor, Transforming Growth Factor-beta Type II
Topics
  • Animals
  • Bone and Bones (metabolism)
  • Cartilage (pathology)
  • Cells, Cultured
  • Male
  • Mesenchymal Stem Cells (physiology)
  • Mice
  • Mice, Inbred C57BL
  • Osteoarthritis (therapy)
  • Protein Serine-Threonine Kinases (antagonists & inhibitors)
  • Rats
  • Rats, Inbred Lew
  • Receptor, Transforming Growth Factor-beta Type II
  • Receptors, Transforming Growth Factor beta (antagonists & inhibitors)
  • Signal Transduction (physiology)
  • Transforming Growth Factor beta (analysis, antagonists & inhibitors, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: